Miroculus
Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Miroculus
Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
TL;DR
What they do: Affordable digital microfluidics platform that automates sample-to-answer molecular testing workflows
Founded: 2014 (San Francisco)
Funding: Total reported funding: 65060000.00 USD; latest round: Series B (2021-02-25)
Exit / status: Acquired by INTEGRA Biosciences (announced 2023)
Founders: Alejandro Tocigl; Foteini (Fay) Christodoulou; Jorge Soto
Company Overview
Problem Domain
Molecular testing and diagnostics; automation of laboratory workflows for molecular assays
Founded
2014
Industry
Biotechnology / health diagnostics
Tech Stack
Funding Track Record
Investor Signal
“Backed by multiple venture investors, including Cota Capital, Kayyak Ventures, Nazca, and Endeavor Catalyst”